Tailored Management of Advanced Esophageal Squamous Cell Carcinoma — Balancing Efficacy and Toxicity with a “Hold Chemotherapy and Keep Immunotherapy” Strategy: A Case Report

Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy with a poor prognosis in advanced stages. Pivotal trials including ATTRACTION-3, CheckMate 648, and CheckMate 577 have demonstrated that immunotherapy with nivolumab significantly improved survival and maintained disease control....

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Journal of Cancer Research and Practice
المؤلفون الرئيسيون: Yu-Chieh Lin, Jeng-Shiun Du, Chun-Chieh Wu
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Wolters Kluwer Medknow Publications 2025-04-01
الموضوعات:
esophageal squamous cell carcinoma
immunotherapy
maintenance therapy
الوصول للمادة أونلاين:https://journals.lww.com/10.4103/ejcrp.eJCRP-D-25-00007

الانترنت

https://journals.lww.com/10.4103/ejcrp.eJCRP-D-25-00007

مواد مشابهة